U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C15H17N3
Molecular Weight 239.3156
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 1
Charge 0

SHOW SMILES / InChI
Structure of 4-(DIMETHYLAMINO)-3'-METHYLAZOBENZENE

SMILES

CN(C)C1=CC=C(C=C1)\N=N\C2=CC=CC(C)=C2

InChI

InChIKey=LVTFSVIRYMXRSR-WUKNDPDISA-N
InChI=1S/C15H17N3/c1-12-5-4-6-14(11-12)17-16-13-7-9-15(10-8-13)18(2)3/h4-11H,1-3H3/b17-16+

HIDE SMILES / InChI

Approval Year

PubMed

PubMed

TitleDatePubMed
Chronic alcohol consumption prevents 8-hydroxyguanine accumulation in 3'-methyl-4-dimethylaminoazobenzene-treated mouse liver.
2009-09-18
Hepatic gap junctions in the hepatocarcinogen-resistant DRH rat.
2008-09
Formate excretion in urine of rats fed dimethylaminoazobenzene-rich diets: the possibility of formate formation from D-lactate.
2008-06
FOXA transcription factors determine the amplitude of glucocorticoid induction of tyrosine aminotransferase in mice.
2007-11
Species-specific effects of the hepatocarcinogens 3'-methyl-4-dimethyl-aminoazobenzene and ortho-aminoazotoluene in mouse and rat liver.
2005-12
Prevention of rat hepatocarcinogenesis by acyclic retinoid is accompanied by reduction in emergence of both TGF-alpha-expressing oval-like cells and activated hepatic stellate cells.
2005
Genetic resistance to chemical hepatocarcinogenesis in the DRH rat strain.
2004-08
Detection of a smaller, 32-kDa 8-oxoguanine DNA glycosylase 1 in 3'-methyl-4-dimethylamino-azobenzene-treated mouse liver.
2004-02
Potential role of p53 mutation in chemical hepatocarcinogenesis of rats.
2004-01
Species specific hepatocarcinogen inhibition of the glucocorticoid induction of tyrosine aminotransferase gene in mouse and rat liver.
2003-05
[Quantitative analysis of p53 and related genes mRNA in rat hepatocarcinogenesis induced by 3'-Me-DAB].
2003-01
Resistance of DRH strain rats to chemical carcinogenesis of liver: genetic analysis of later progression stage.
2002-01
Effects of gomisin A on the promotor action and serum bile acid concentration in hepatocarcinogenesis induced by 3'-methyl-4-dimethylamino-azobenzene.
1995-10
Synergistic effects of low-dose hepatocarcinogens in induction of glutathione S-transferase P-positive foci in the rat liver.
1989-10
Dose-dependent induction of liver and thyroid neoplastic lesions by short-term administration of 2-amino-3-methylimidazo[4,5-f]quinoline combined with partial hepatectomy followed by phenobarbital or low dose 3'-methyl-4-dimethylaminoazobenzene promotion.
1988-06
Promotion of hepatocarcinogenesis by suxibuzone in rats initiated with 3'-methyl-4-dimethylaminoazobenzene.
1987-07
Inhibition of neoplastic development in rat liver, kidney, oesophagus and forestomach by 4,4'-diaminodiphenylmethane administration.
1987-05
Effect of timing of partial hepatectomy on the induction of preneoplastic liver foci in rats given hepatocarcinogens.
1986-07
Promoting and anticarcinogenic effects of phenobarbital and DDT in the rat hepatocarcinogenesis.
1986
Promoting effects of phenobarbital and 3'-methyl-4-dimethylaminoazobenzene on the appearance of gamma-glutamyltranspeptidase positive foci in rat liver pretreated with varying doses of diethylnitrosamine.
1985-09-15
Different responses to phenobarbital promotion in the development of gamma-glutamyltranspeptidase-positive foci in the liver of rats initiated with diethylnitrosamine, N-hydroxy-2-acetyl-aminofluorene and aflatoxin B1.
1985-01
Dose-response studies on promoting and anticarcinogenic effects of phenobarbital and DDT in the rat hepatocarcinogenesis.
1984-12
Modifying potential of thirty-one chemicals on the short-term development of gamma-glutamyl transpeptidase-positive foci in diethylnitrosamine-initiated rat liver.
1984-10
Comparison of the promoting effects of various agents in induction of preneoplastic lesions in rat liver.
1983-04
Induction of hyperplastic liver nodules in hepatectomized rats treated with 3'-methyl-4-dimethylaminoazobenzene, benzo[a]pyrene or phenobarbital before or after exposure to N-2-fluorenylacetamide.
1982-04
Promotion by dietary phenobarbital of hepatocarcinogenesis by 2-methyl-N,N-dimethyl-4-aminoazobenzene in the rat.
1979-01
The importance of an innervated and intact antrum and pylorus in preventing postoperative duodenogastric reflux and gastritis.
1975-10
Patents

Patents

Name Type Language
4-(DIMETHYLAMINO)-3'-METHYLAZOBENZENE
Systematic Name English
NSC-59783
Preferred Name English
3'-METHYL-4-(DIMETHYLAMINE)AZOBENZENE
Common Name English
M'-METHYL-P-DIMETHYLAMINOAZOBENZENE
Common Name English
3'-METHYL-4-(N,N-DIMETHYLAMINO)AZOBENZENE
Systematic Name English
BENZENAMINE, N,N-DIMETHYL-4-((3-METHYLPHENYL)AZO)-
Systematic Name English
4-(N,N-DIMETHYLAMINO)-3'-METHYLAZOBENZENE
Systematic Name English
4-DIMETHYLAMINO-3'-METHYLAZOBENZENE
Systematic Name English
3'-METHYL-4-DIMETHYLAMINOAZOBENZENE
Systematic Name English
3'-METHYL-N,N-DIMETHYL-4-AMINOAZOBENZENE
Common Name English
N,N-DIMETHYL-4-(3-METHYLPHENYLAZO)ANILINE
Systematic Name English
ANILINE, N,N-DIMETHYL-P-(M-TOLYLAZO)-
Systematic Name English
N,N-DIMETHYL-P-(M-TOLYLAZO)ANILINE
Common Name English
BENZENAMINE, N,N-DIMETHYL-4-(2-(3-METHYLPHENYL)DIAZENYL)-
Systematic Name English
ANILINE, N,N-DIMETHYL-P-(3'-METHYLPHENYLAZO)-
Systematic Name English
N,N-DIMETHYL-4-((3-METHYLPHENYL)AZO)BENZENAMINE
Systematic Name English
METHYLDIMETHYLAMINOAZOBENZENE
Systematic Name English
3',N,N-TRIMETHYL-4-AMINOAZOBENZENE
Common Name English
3-METHYL-4'-(DIMETHYLAMINO)AZOBENZENE [HSDB]
Common Name English
N,N-DIMETHYL-4-(M-TOLYLAZO)ANILINE
Systematic Name English
N,N,3'-TRIMETHYL-4-AMINOAZOBENZENE
Common Name English
Code System Code Type Description
FDA UNII
SXK3ZE3U4Q
Created by admin on Mon Mar 31 22:23:03 GMT 2025 , Edited by admin on Mon Mar 31 22:23:03 GMT 2025
PRIMARY
NSC
59783
Created by admin on Mon Mar 31 22:23:03 GMT 2025 , Edited by admin on Mon Mar 31 22:23:03 GMT 2025
PRIMARY
EPA CompTox
DTXSID8020838
Created by admin on Mon Mar 31 22:23:03 GMT 2025 , Edited by admin on Mon Mar 31 22:23:03 GMT 2025
PRIMARY
ECHA (EC/EINECS)
200-243-4
Created by admin on Mon Mar 31 22:23:03 GMT 2025 , Edited by admin on Mon Mar 31 22:23:03 GMT 2025
PRIMARY
HSDB
5071
Created by admin on Mon Mar 31 22:23:03 GMT 2025 , Edited by admin on Mon Mar 31 22:23:03 GMT 2025
PRIMARY
CAS
55-80-1
Created by admin on Mon Mar 31 22:23:03 GMT 2025 , Edited by admin on Mon Mar 31 22:23:03 GMT 2025
PRIMARY
CHEBI
76329
Created by admin on Mon Mar 31 22:23:03 GMT 2025 , Edited by admin on Mon Mar 31 22:23:03 GMT 2025
PRIMARY